PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu
PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu Detail:
Manufacturer Supply, High Purity, Commercial Production
Chemical Name: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5
Chemical Name | 2-Chloro-5-Iodobenzoic Acid |
CAS Number | 19094-56-5 |
CAT Number | RF-PI438 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C7H4ClIO2 |
Molecular Weight | 282.46 |
Solubility | Soluble in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White or Pale Yellow Crystals |
Assay / Analysis Method | ≥99.0% (HPLC) |
Melting Point | 161.0~163.0℃ |
Loss on Drying | ≤0.50% |
Residue on Ignition | ≤0.20% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Residual Solvent | Ethanol |
Test Standard | Enterprise Standard |
Usage | Intermediate of Empagliflozin (CAS: 864070-44-0) |
2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Synthetic Route
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) can be used as a pharmaceutical intermediate in the synthesis of Empagliflozin (CAS: 864070-44-0). Empagliflozin (trade name Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine. On August 1, 2014, the Food and Drug Administration (FDA) officially approved the drug for the treatment of type 2 diabetes, to improve and control blood glucose of adults. Empagliflozin is the third SGLT-2 inhibiting drugs approved by FDA. Another two SGLT-2 inhibitor drugs, Canagliflozin and Dapagliflozin, belonging to Johnson Pharmaceuticals, AstraZeneca and Bristol-Myers Squibb respectively, are approved by FDA in November 2013 and January 2014 respectively.
Product detail pictures:
Related Product Guide:
We continuously execute our spirit of ''Innovation bringing development, Highly-quality ensuring subsistence, Management advertising and marketing gain, Credit history attracting buyers for PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu , The product will supply to all over the world, such as: Nigeria, Botswana, Madrid, They're durable modeling and promoting well all over the world. Under no circumstances disappearing key functions in a brief time, it's a must for yourself personally of fantastic quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the business make an awesome efforts to expand its international trade, raise its enterprise. rofit and improve its export scale. We have been confident that we will have a vibrant prospect and to be distributed all over the world in the years to come.
By Maria from Niger - 2017.08.18 18:38
Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.
By Marian from Israel - 2017.05.21 12:31